Your browser doesn't support javascript.
loading
Immune activation by DNA damage predicts response to chemotherapy and survival in oesophageal adenocarcinoma.
Turkington, Richard C; Knight, Laura A; Blayney, Jaine K; Secrier, Maria; Douglas, Rosalie; Parkes, Eileen E; Sutton, Eilis K; Stevenson, Leanne; McManus, Damian; Halliday, Sophia; McCavigan, Andrena M; Logan, Gemma E; Walker, Steven M; Steele, Christopher J; Perner, Juliane; Bornschein, Jan; MacRae, Shona; Miremadi, Ahmad; McCarron, Eamon; McQuaid, Stephen; Arthur, Kenneth; James, Jacqueline A; Eatock, Martin M; O'Neill, Robert; Noble, Fergus; Underwood, Timothy J; Harkin, D Paul; Salto-Tellez, Manuel; Fitzgerald, Rebecca C; Kennedy, Richard D.
Afiliación
  • Turkington RC; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Knight LA; Almac Diagnostics Ltd, Craigavon, UK.
  • Blayney JK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Secrier M; Genetics Institute, University College London, London, UK.
  • Douglas R; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Parkes EE; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Sutton EK; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Stevenson L; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • McManus D; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
  • Halliday S; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • McCavigan AM; Almac Diagnostics Ltd, Craigavon, UK.
  • Logan GE; Almac Diagnostics Ltd, Craigavon, UK.
  • Walker SM; Almac Diagnostics Ltd, Craigavon, UK.
  • Steele CJ; Almac Diagnostics Ltd, Craigavon, UK.
  • Perner J; Cancer Research UK Cambridge Institute, University of Cambridge, Cambridge, UK.
  • Bornschein J; Translational Gastroenterology Unit, John Radcliffe Hospital Oxford University Hospitals NHS Trust, Oxford, UK.
  • MacRae S; Hutchison/MRC Research Centre, Cambridge, UK.
  • Miremadi A; Department of Histopathology, Addenbrookes Hospital, Cambridge, UK.
  • McCarron E; Department of Pathology, Belfast Health and Social Care Trust, Belfast, UK.
  • McQuaid S; Northern Ireland Molecular Pathology Laboratory, Queen's University Belfast, Belfast, UK.
  • Arthur K; Northern Ireland Molecular Pathology Laboratory, Queen's University Belfast, Belfast, UK.
  • James JA; Northern Ireland Molecular Pathology Laboratory, Queen's University Belfast, Belfast, UK.
  • Eatock MM; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • O'Neill R; Department of Medical Oncology, Belfast Health and Social Care Trust, Belfast, UK.
  • Noble F; Edinburgh Cancer Research Centre, University of Edinburgh, Edinburgh, UK.
  • Underwood TJ; Department of Surgery, University Hospital Southampton NHS Foundation Trust, Southampton, UK.
  • Harkin DP; Cancer Sciences Division, University of Southampton, Southampton, UK.
  • Salto-Tellez M; Almac Diagnostics Ltd, Craigavon, UK.
  • Fitzgerald RC; Centre for Cancer Research and Cell Biology, Queen's University Belfast, Belfast, UK.
  • Kennedy RD; Hutchison/MRC Research Centre, Cambridge, UK.
Gut ; 68(11): 1918-1927, 2019 11.
Article en En | MEDLINE | ID: mdl-30852560
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daño del ADN / Neoplasias Esofágicas / Adenocarcinoma / Esofagectomía / Terapia Neoadyuvante / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Daño del ADN / Neoplasias Esofágicas / Adenocarcinoma / Esofagectomía / Terapia Neoadyuvante / Antineoplásicos Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Gut Año: 2019 Tipo del documento: Article País de afiliación: Reino Unido Pais de publicación: Reino Unido